Studies on Reversing Effect of Multidrug Resistance by Dipyridamole. I. Modulation of Epirubicin-Induced Effects on Cell Proliferation and Cell Cycle by Dipyridamole

DOI Web Site Web Site 1 Citations 25 References

Bibliographic Information

Other Title
  • ジピリダモールの多剤耐性克服作用に関する研究(第1報)ジピリダモールによるエピルビシンの細胞増殖, 細胞周期に対する作用の修飾
  • ジピリダモール ノ タザイ タイセイ コクフク サヨウ ニカンスルケンキュウ

Search this article

Description

Dipyridamole, a nucleoside membrane transport inhibitor, enhanced the cytotoxicity of epirubicin for mouse leukemia P388 cells by a factor of 1.8-fold and that for 30-fold doxorubicin-resistant sublines of P388 cells (P388/DOX) by a factor of 6.5-fold. This interaction was shown to be truly synergistic by DNA histogram and median effect analysis. The dipyridamole enhancement of the cytotoxicity of epirubicin was a dose-dependent effect ; it was greatest when cells were exposed to dipyridamole before treatment with epirubicin. In cell cycle experiments, 1-5μM dipyridamole increased the accumulation of G2+M phase produced by the treatment with 0.5-1μM epirubicin. Dipyridamole, however, did not appear to alter the patterns of DNA histogram in sensitive cells. These results suggest that the increase of the accumulation of G2+M phase in resistant cells is an important factor for the interaction between epirubicin and dipyridamole.

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 116 (3), 217-227, 1996

    The Pharmaceutical Society of Japan

Citations (1)*help

See more

References(25)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top